Financial Advocates Investment Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$612K Sell
1,510
-496
-25% -$201K 0.05% 316
2025
Q1
$998K Sell
2,006
-230
-10% -$114K 0.07% 275
2024
Q4
$1.16M Sell
2,236
-1,499
-40% -$780K 0.07% 269
2024
Q3
$2.31M Sell
3,735
-15
-0.4% -$9.28K 0.13% 164
2024
Q2
$2.07M Sell
3,750
-475
-11% -$263K 0.13% 168
2024
Q1
$2.46M Buy
4,225
+118
+3% +$68.6K 0.14% 160
2023
Q4
$2.18M Buy
4,107
+204
+5% +$108K 0.14% 163
2023
Q3
$1.98M Buy
3,903
+14
+0.4% +$7.09K 0.14% 164
2023
Q2
$2.03M Sell
3,889
-68
-2% -$35.5K 0.14% 160
2023
Q1
$2.28M Buy
3,957
+606
+18% +$349K 0.16% 141
2022
Q4
$1.85M Buy
3,351
+63
+2% +$34.7K 0.14% 173
2022
Q3
$1.67M Buy
3,288
+287
+10% +$146K 0.14% 167
2022
Q2
$1.63M Buy
3,001
+582
+24% +$316K 0.13% 192
2022
Q1
$1.43M Buy
2,419
+176
+8% +$104K 0.09% 236
2021
Q4
$1.5M Sell
2,243
-18
-0.8% -$12K 0.09% 245
2021
Q3
$1.34M Sell
2,261
-3,688
-62% -$2.18M 0.09% 254
2021
Q2
$1.09M Buy
5,949
+3,112
+110% +$572K 0.07% 290
2021
Q1
$1.29M Buy
2,837
+45
+2% +$20.5K 0.09% 250
2020
Q4
$1.3M Buy
2,792
+104
+4% +$48.4K 0.09% 255
2020
Q3
$1.19M Sell
2,688
-34
-1% -$15K 0.1% 207
2020
Q2
$986K Buy
2,722
+53
+2% +$19.2K 0.09% 240
2020
Q1
$757K Buy
2,669
+402
+18% +$114K 0.11% 216
2019
Q4
$736K Buy
2,267
+562
+33% +$182K 0.08% 247
2019
Q3
$496K Buy
1,705
+3
+0.2% +$873 0.06% 285
2019
Q2
$500K Buy
1,702
+84
+5% +$24.7K 0.06% 290
2019
Q1
$443K Sell
1,618
-39
-2% -$10.7K 0.06% 293
2018
Q4
$371K Sell
1,657
-307
-16% -$68.7K 0.05% 295
2018
Q3
$479K Buy
1,964
+51
+3% +$12.4K 0.05% 293
2018
Q2
$393K Sell
1,913
-230
-11% -$47.3K 0.05% 309
2018
Q1
$442K Buy
2,143
+13
+0.6% +$2.68K 0.06% 281
2017
Q4
$404K Buy
+2,130
New +$404K 0.06% 291